CMS and manufacturers may renegotiate terms in the future depending on certain circumstances such as changes in the FDA labeling, new clinical evidence, or new products launched
Before enrolling with any platform, patients should verify the most current information about its compliance standing and pharmacy certifications
While their therapeutic benefits are well-established, the relationship between GLP-1RAs and cancer risk has become a critical focus of clinical investigation
The word "Ratatouille" is TikTok slang for Retatrutide
Many health plans, including BCBS, Priority Health and UHC in Michigan, do not cover GLP-1 drugs when prescribed specifically for weight loss , which can leave employees wondering what, if any, alternatives exist
As of early 2026, multiple Phase 3 trials have reported positive topline results, regulatory submissions have been filed, and the FDA is reviewing orforglipron for an obesity indication with a target action date of April 10, 2026